DYN
NASDAQ
US
Dyne Therapeutics, Inc. - Common Stock
$18.84
▲ +$0.74
(+4.09%)
Vol 1.9M
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$3.2B
ROE
-66.2%
D/E
14.33
Beta
1.32
52W
$6–$26
Wall Street Consensus
20 analysts · Apr 20267
Strong Buy
10
Buy
3
Hold
0
Sell
0
Strong Sell
85.0%
Buy Rating
Price Chart
Similar Stocks
ACAD
ACADIA Pharmaceuticals Inc
P/E 17.3
$4.5B
SYRE
Spyre Therapeutics Inc
$2.5B
LEGN
Legend Biotech Corp
$4.0B
DNLI
Denali Therapeutics Inc
$2.6B
TNGX
Tango Therapeutics Inc
$1.2B
TWST
Twist Bioscience Corp
$1.9B
CPRX
Catalyst Pharmaceuticals Inc
P/E 13.2
$2.9B
ARQT
Arcutis Biotherapeutics Inc
$3.6B
VERA
Vera Therapeutics, Inc
$3.5B
Earnings
Beat rate: 50.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $-0.78 | $-0.76 | +$0.02 |
| Sep 2025 | $-0.85 | $-0.76 | +$0.09 |
| Jun 2025 | $-0.96 | $-0.97 | $-0.01 |
| Mar 2025 | $-0.89 | $-1.05 | $-0.16 |
Quarterly Revenue & Earnings
| Quarter | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -$89.5M | -$115.4M | -$110.9M | -$108.0M | -$112.0M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -64.1% | -64.1% | -64.1% | -64.1% | -66.2% | -66.2% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 17.29 | 17.29 | 17.29 | 17.29 | 14.33 | 14.33 |
| Current Ratio | 16.83 | 16.83 | 16.83 | 16.83 | 13.47 | 13.47 |
Key Ratios
ROA (TTM)
-56.4%
P/B
3.8
EPS (TTM)
$-3.66
CF/Share
$-3.59
52W High
$26.22
52W Low
$6.36
$6.36
52-Week Range
$26.22
Financial Health
Free Cash Flow
-$112.3M
Net Debt
-$724.2M
Cash
$893.4M
Total Debt
$169.2M
As of Dec 31, 2025
How does DYN compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
DYN valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
3.8
▲
55%
above
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
DYN profitability vs Biotechnology peers
ROE
-66.2%
▲
2%
above
peers
(-67.3%)
vs Peers
vs Industry
In line
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-56.4%
▼
21%
below
peers
(-46.7%)
vs Peers
vs Industry
Below avg
DYN financial health vs Biotechnology peers
D/E ratio
14.3
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
High debt
Current ratio
13.5
▲
203%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
1.3
▲
36%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
DYN fundamentals radar
DYN
Peer median
Industry
DYN profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
DYN vs peers: key metrics
Insider Activity
NeutralBuys
0
Sells
0
POSNER BRIAN S.
Director · Mar 11
2000 shs
KERSTEN DIRK
Director · Mar 11
129672 shs
KERSTEN DIRK
Director · Mar 10
688788 shs
POSNER BRIAN S.
Director · Mar 06
3000 shs
KERR DOUGLAS
Officer · Mar 05
904 shs
COX JOHN
Chief Executive Officer · Mar 05
2732 shs
FRIEDL-NADERER JOHANNA
Officer · Mar 05
148 shs
LUCERA ERICK J.
Chief Financial Officer · Feb 12
65000 shs
KERR DOUGLAS
Officer · Feb 12
85000 shs
COX JOHN
Chief Executive Officer · Feb 12
180000 shs
Last 90 days
Top Holders
Top 5: 38.16%T. Rowe Price Investment Ma…
10.63%
$300.6M
Janus Henderson Group PLC
8.42%
$238.0M
Vanguard Group Inc
6.80%
$192.2M
Blackrock Inc.
6.78%
$191.8M
Atlas Venture Life Science …
5.53%
$156.5M
As of Dec 31, 2025
Latest News
Earnings Preview: What to Expect From Teledyne Technologies' Report
Yahoo Finance · Mar 31
General Dynamics' Q1 2026 Earnings: What to Expect
Yahoo Finance · Mar 31
AI-Driven Dynamics Propelled Lam Research (LRCX) Shares in Q4
Yahoo Finance · Mar 27
Steel Dynamics Stock: Is STLD Outperforming the Basic Materials Sector?
Yahoo Finance · Mar 24
B. Riley Lifts Global Ship Lease (GSL) Outlook on Strong Industry Dynamics
Yahoo Finance · Mar 20